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Abstract: Forebrain neurons have relatively weak intrinsic antioxidant defenses compared to
astrocytes, in part due to hypo-expression of Nrf2, an oxidative stress-induced master regulator of
antioxidant and detoxification genes. Nevertheless, neurons do possess the capacity to auto-regulate
their antioxidant defenses in response to electrical activity. Activity-dependent Ca2+ signals control the
expression of several antioxidant genes, boosting redox buffering capacity, thus meeting the elevated
antioxidant requirements associated with metabolically expensive electrical activity. These genes
include examples which are reported Nrf2 target genes and yet are induced in a Nrf2-independent
manner. Here we discuss the implications for Nrf2 hypofunction in neurons and the mechanisms
underlying the Nrf2-independent induction of antioxidant genes by electrical activity. A significant
proportion of Nrf2 target genes, defined as those genes controlled by Nrf2 in astrocytes, are regulated
by activity-dependent Ca2+ signals in human stem cell-derived neurons. We propose that neurons
interpret Ca2+ signals in a similar way to other cell types sense redox imbalance, to broadly induce
antioxidant and detoxification genes.
Keywords: neuroprotection; neurodegeneration; oxidative stress; signal transduction; synaptic
activity; gene transcription; antioxidants; astrocytes
1. The Nrf2 Pathway Is Weak in Neurons
When placed alone in the absence of supporting glial cells, forebrain neurons have a lower capacity
than astrocytes to withstand oxidative insults., particularly those involving peroxide exposure or
generation. The principle peroxide-detoxifying system in non-neuronal cells, the glutathione (GSH)
system, has low capacity in neurons compared to astrocytes and neurons store far less glutathione than
their glial neighbors [1,2]. As a result they rely on nearby glia for antioxidant support: in response to
oxidative stress astrocytes release glutathione which is broken down and taken up by neurons for their
own use [3–7]. Other glutathione-utilizing enzymes (specifically glutathione transferase M2-2) have
also been reported to be secreted by glia for uptake by neurons with neuroprotective consequences [8].
In astrocytes, as with many cell types, glutathione steady state levels are maintained through a
feedback inhibitory mechanism whereby GSH inhibits the rate determining step in GSH biosynthesis,
catalyzed by Glutamate-cysteine ligase (GCL). However, glutathione biosynthetic capacity is further
regulated at the transcriptional level by a clever system that (most cells) possess to homeostatically
regulate antioxidant, detoxification and cytoprotective genes in response to metabolic challenge. This
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system is centered on the transcription factor Nrf2 [9–11], constitutively translated but ordinarily
targeted for ubiquitin-mediated degradation by its inhibitor Keap1. However, in response to oxidative
stress, one or more of Keap1′s redox-sensitive cysteine residues become oxidized, preventing Nrf2′s
degradation, causing its accumulation and translocation to the nucleus [12,13]. Here, Nrf2 induces the
expression of genes whose promoters contain its cognate binding site, referred to as the Antioxidant
Response Element (ARE) [14]. Keap1 also possesses sensors for heavy metal stress, alkenals and nitric
oxide, thus offering a variety of mechanisms by which cells sense stress and turn on a battery of
ARE-containing genes [15,16]. In the brain, Nrf2 signaling is activated in astrocytes, contributing to
ischemic preconditioning [16,17].
In contrast to astrocytes and most other cell types, forebrain neurons have a very weak Nrf2
pathway, due to expressing Nrf2 mRNA at very low levels, compared to astrocytes, in both rodent
and human systems [3,18]. Moreover, what little Nrf2 is present in neurons is highly unstable [19]. As
a result, any stresses that prevent Keap1-mediated degradation are ineffective simply because there
is too little Nrf2 present in the first place [18]. Even genetic deletion of Keap1 has no effect on Nrf2
target genes in cortical neurons, unlike in other cell types such as astrocytes which exhibit a marked
induction of basal expression of Nrf2 target genes. Examination of the relative level of expression of
Nrf2 target genes reveals that they are much lower in neurons than astrocytes and that genetic deletion
of Nrf2 lowers Nrf2 target gene expression in astrocytes, it has no effect in neurons [18]. Thus, Nrf2
contributes little to the basal expression of ARE-containing genes in neurons.
2. The Forebrain Neuronal Nrf2 Pathway Is Developmentally Shut off
The very low expression of Nrf2 in neurons compared to astrocytes is surprising given that
both arise from the same population of neural progenitor cells. Interestingly, very young neurons do
express quite high levels of Nrf2 and respond to Nrf2 activating stimuli with the accumulation of Nrf2
and induction of Nrf2 target genes [18]. However, as neurons mature, so levels of Nrf2 decline by a
mechanism involving the epigenetic repression of the Nrf2 promoter leading to histone hypoacetylation
around the Nrf2 transcription start site. The biological reason developing neurons should require
the shut-off of the Nrf2 pathway is not fully understood, however clues have come from observing
the effects of ectopically expressing Nrf2 in developing neurons at a time when it is ordinarily being
repressed. While Nrf2 expression at this stage has the expected effect of enhancing antioxidant defenses
and rendering neurons resistance to oxidative insults, it also had the effect of inhibiting development,
with both dendritic outgrowth and arborization and synaptogenesis, severely retarded [18]. The basis
of these effects by Nrf2 appears to be the repression of redox-sensitive signaling pathways critical for
development, including the Wnt and c-Jun N-terminal kinase (JNK) pathways [18]. It remains to be
seen whether Nrf2 pathway hypofunction is also a feature of other neuronal cell types, such as those
in the cerebellum, striatum, midbrain and spinal cord, so the following sections apply primarily to
cortical neurons.
3. Metabolic Adaption Induced by Neuronal Ca2+ Signals
Neuronal Nrf2 levels remain low in maturity, robbing them of an important stress response
pathway. It could be argued that neurons in particular would benefit from a functional Nrf2 pathway:
they are highly metabolically active, consuming large amounts of adenosine triphosphate (ATP) to
maintain their resting membrane potential. Moreover, their primary source of energy is oxidative
phosphorylation, a process that can lead to reactive oxygen species (ROS) production when electrons
escape the transport chain. Importantly, this energy requirement and attendant ROS production,
increases dramatically when neurons are electrically active [20,21]. Rather than simply maintaining
ionic balance and membrane potential in the face of leak currents, the neuron must restore these
balances after membrane depolarization, clear the synapse of neurotransmitter and replenish vesicle
pools, all of which involve energy-requiring transport against concentration gradients. To meet
these increased demands for energy, neurons do not just rely on laws of mass action: Ca2+ influx,
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triggered following membrane depolarization (through voltage-gated Ca2+ channels) or excitatory
neurotransmitter release (e.g., through glutamate-gated N-Methyl D-Aspartate (NMDA) receptors)
actively promote oxidative phosphorylation. Cytoplasmic Ca2+ - activates the Aralar component
of the malate–aspartate shuttle (MAS) which functions to deliver reducing equivalents into the
mitochondria and promotes pyruvate production [22,23]. Additionally, mitochondrial Ca2+ triggers
the activation (and dephosphorylation) of pyruvate dehydrogenase, as well as activating several Ca2+
dependent enzymes within the tricarboxylic acid (TCA) cycle [24–27]. Thus, activity-dependent Ca2+
signals help the neuron to meet elevated energy demands, however, the side effect is increased ROS
production [26,28–32], GSH utilization [33] and consequent need for enhanced antioxidant capacity.
4. Neuronal Regulation of Antioxidant Defenses
At face value, this coupling of enhanced ROS production to increased intrinsic antioxidant
defenses would appear an ideal role for Nrf2 to play, however this mechanism is not available to
neurons. Nevertheless, activity-dependent Ca2+ signals do lead to the transcriptional induction
of antioxidant genes and consequently elevated capacity of both the glutathione and thioredoxin
antioxidant systems [33–35]. For example, activity-dependent induction of catalytic (Gclc) and modifier
(Gclm) subunits of glutamyl-cysteine ligase increase neuronal GSH biosynthesis capacity, boosting
antioxidant defenses in vitro and in vivo. Indeed, reducing activity-dependent Ca2+ transients in vivo
(by NMDAR antagonism) uncouples activity from Gclc expression, which leads to GSH depletion
and neurodegeneration [33]. Interestingly, several of the antioxidant pathway genes induced by
activity-dependent Ca2+ signals, such as Gclc, Gclm, Gsr, Srxn and Txnrd1 and Slc7a11 are known Nrf2
target genes, so how can neurons promote their expression if their Nrf2 pathway is not functional?
5. Neuronal Ca2+ Signals Can Induce Nrf2 Target Genes Independently of Nrf2
One fact often overlooked in the study of Nrf2 target genes is their potential to be controlled
by transcription factors other than Nrf2. The transcription factor family AP-1 (Fos/Jun) is a known
regulator of a number of known Nrf2 target genes, including Srxn1, Hmox1 and Nqo1. Interestingly,
in these genes the Nrf2 binding ARE (typical consensus TMAnnRTGA(Y/G)nnnGCR) contains an
embedded AP-1 site. For example the mouse Srxn1 ARE sequence is TCACCCTGAGTCAGCG and
the mouse Hmox1 ARE sequence is TCTGCTGAGTCAAGGTCCG (the AP-1 consensus sequences are
underlined) [36,37]. Several studies have shown that AP-1 can contribute to the basal expression of
ARE-containing genes, which can be further induced by Nrf2-activating stimuli [36]. Of course, most
signal responsive promoters contain multiple elements, offering further scope for Nrf2-independent
control of “Nrf2 target genes”. A well-studied example is the ARE-containing gene Slc7a11, which
encodes the cystine/glutamate antiporter xCT. The Slc7a11 promoter also contains binding sites for
the transcription factor ATF-4, offering an alternative route to its transcriptional regulation [38].
Given this, there is scope for Nrf2 target genes to be induced in a Nrf2-independent manner. This
has been confirmed in the case of two examples: activity-dependent induction of mouse Srxn1 is
Nrf2-independent [39] and AP-1 dependent [40], while activity-dependent induction of mouse Slc7a11
is Nrf2-independent and is ATF-4 dependent [41].
Thus, it is clear that certain Nrf2 target genes can be regulated by activity-dependent Ca2+
signals despite not having a functional Nrf2 pathway. However, it does not tell us what proportion
of Nrf2 target genes can be controlled in this way by electrical activity. To gain an impression
of this, we interrogated our previously reported RNA-seq data set of activity-dependent gene
expression in human embryonic stem cell-derived neurons [42]. In this study we generated dissociated
glutamatergic cortical-patterned neurons from human embryonic stem cells (hESCCORT-neurons) [43,44]
and studied transcriptional responses to Ca2+ influx through l-type Ca2+ channel activation, achieved
by KCl-induced membrane depolarization in the presence of the l-type Ca2+ channel agonist FPL64176
(KCl/FPL). Two timepoints were studied: 4 h and 24 h. We then cross-referenced this data set against a
set of Nrf2-regulated genes, curated from an RNA-seq data set of astrocytes sorted from transgenic
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mice which overexpress Nrf2 specifically in astrocytes [45] (GFAP-Nrf2). 59 genes are induced >2-fold
in GFAP-Nrf2 astrocytes (relative to wild-type astrocytes) that were expressed > 1FPKM on average in
the hESCCORT-neurons (data not shown). Of these 59 genes, 39 genes were found to be significantly
induced in hESCCORT-neurons (p < 0.05) at either 4 h or 24 h timepoints, including GCLC, GCLM, GSR,
NQO1, TXNRD1 CAT and SLC7A11 and only 6 genes were significantly down-regulated (Figure 1).
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Figure 1. Log2 fold change of the indicated Nrf2-regulated genes in human embryonic stem cell
(ESC)-derived cortical neurons stimulated with high K+ for the indicated period of time. The data
come from a meta-analysis of that published previously [42]. * p <0.05 (n = 3).
Collectively this illustrates that a substantial proportion of Nrf2-regulated genes can be controlled
by Ca2+ signals in human neurons. It makes teleological sense to mount an adaptive/protective
response to Ca2+ signals, since substantial or repetitive Ca2+ influx into neurons places metabolic
demands on neurons which may be unsustainable or injurious in the absence of adaption [46–49].
This type of metabolic homeostatic control regulated by Ca2+ signals draws parallels with other Ca2+
-dependent rebalancing processes in neurons, such as homeostatic plasticity of synaptic and intrinsic
properties [50–52]. That said, Ca2+ signals control several programs of cytoprotective gene expression
that Nrf2 is not implicated in, such as the repression of apoptotic genes and FOXO-dependent gene
expression [53,54], the induction of nuclear calcium and CREB-dependent pro-survival genes [55–58]
and the manipulation of TrkB signaling [59]. Moreover, it is important to note that all the aforementioned
effects of Ca2+ signals are in response to non-toxic, physiological levels of Ca2+, excessive Ca2+ influx,
particularly through extrasynaptic NMDA receptors, induces a very different gene expression profile
which has a net toxic, rather than protective effect [60–62].
6. Concluding Remarks
It remains to be seen whether Ca2+ signals regulate Nrf2 target genes in other excitable cells, such
as those of smooth and skeletal muscle or cell types where Ca2+ signals herald major metabolic or
developmental changes, such as oocytes and T-cells. Nevertheless, the overlap between the neuronal
activity-dependent transcriptome and the Nrf2-regulated transcriptome suggest that neurons interpret
Ca2+ signals in a similar way to other cell types sense oxidative stress, to broadly induce antioxidant
and cytoprotective genes to confer greater cellular resilience in the face of greater metabolic demand.
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